美国DRG下高值创新医疗技术的支付政策及启示

吴晶, 董心月, 赵博雅

中国医疗保险 ›› 2022, Vol. 0 ›› Issue (6) : 118-124.

中国医疗保险 ›› 2022, Vol. 0 ›› Issue (6) : 118-124. DOI: 10.19546/j.issn.1674-3830.2022.6.025
国际(地区)比较

美国DRG下高值创新医疗技术的支付政策及启示

  • 吴晶, 董心月, 赵博雅
作者信息 +

The Payment Policy and Enlightenment of High-value Innovative Medical Technology under DRG in the United States

Author information +
文章历史 +

摘要

本文系统总结了美国在MS-DRG支付系统下,针对高值创新医疗技术支付的改革与经验。具体总结了其对高值创新医疗技术的长期支付机制与短期支付机制下的新技术附加支付、异常值支付和共同支付政策。以期为我国在推进医保支付方式改革、促进医疗费用科学使用的同时,探索建立兼顾医学进步、高值创新医疗技术合理应用与推广的激励机制提供参考。

Abstract

This paper systematically summarizes the reform and experience of high-value innovative medical technology payment under the MS-DRG payment system in the United States. It specifically summarizes its long-term payment mechanism for high-value innovative medical technology and new technology additional payment, abnormal value payment and co-payment policies under the short-term payment mechanism. It is expected to provide a reference for China to explore and establish an incentive mechanism that takes into account medical advancement and the rational application and promotion of high-value innovative medical technologies while promoting the reform of medical insurance payment methods and the scientific use of medical expenses.

关键词

美国 / 打包付费 / 高值创新医疗技术 / 短期支付机制 / 长期支付机制

Key words

United States / package payment / high-value innovative medical technology / short-term payment mechanism / long-term payment mechanism

引用本文

导出引用
吴晶, 董心月, 赵博雅. 美国DRG下高值创新医疗技术的支付政策及启示[J]. 中国医疗保险. 2022, 0(6): 118-124 https://doi.org/10.19546/j.issn.1674-3830.2022.6.025
The Payment Policy and Enlightenment of High-value Innovative Medical Technology under DRG in the United States[J]. China Health Insurance. 2022, 0(6): 118-124 https://doi.org/10.19546/j.issn.1674-3830.2022.6.025
中图分类号: F840.684C913.7   

参考文献

1 [[1] Bhattachary J, Hyde T, Tu P. 健康经济学[M]. 桂林: 广西师范大学, 2019: 361-388.
[2] Medpac. Hospital acute inpatient services payment system[EB/OL].2021[2021-12-02]. https://www.medpac.gov/wp-content/uploads/2021/11/medpac_payment_basics_21_hospital_final_sec.pdf.
[3] Simcha BR, Brian DG, Deborah LR.Diagnosis-related Groups and Hospital Inpatient Federal Reimbursement[J]. RadioGraphics, 2015, 36(6): 1825-1834.
[4] CMS. Application for New Medical Services and Technologies Seeking to Quality for Add-On Payments Under the Hospital Inpatient Prospective Payment System for Federal Fiscal Year2023[EB/OL]. 2021[2021-12-02]. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/newtech.
[5] CMS. Example of How to Submit and Case Weight for Cost Criterion[EB/OL].2021[2021-1202]. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/newtech.
[6] CMS. MS-DRG Classification and Software[EB/OL].2021-11-17[2021-12-02]. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/MS-DRG-Classifications-and-Software.
[7] Medicare Part A&B, Nursing Facilities. Fiscal Year (FY) 2022 Medicare Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital (LTCH) Rates Final Rule[EB/OL]. 2021-08-02[2021-12-2]. https://www.cms.gov/newsroom/fact-sheets/fiscal-year-fy-2022-medicare-hospital-inpatient-prospective-payment-system-ipps-and-long-term-care-0.
[8] CMS HHS. Medicare Program; Change in Methodology for Determining Payment for Extraordinarily High-Cost Cases (Cost Outlier) Under the Acute Care Hospital Inpatient and Long Term Care Hospital Prospective Payment Systems[EB/OL].2003-6-9[2021-12-02]. https://www.federalregister.gov/documents/2003/06/09/03-14492/medicare-program-change-in-methodology-for-determining-payment-for-extraordinarily-high-cost-cases.
[9] Maccariella-Hafey P. New Technology Add-on Payments (NTAP) for FY2021-Part 4[EB/OL]. 2020-10-28[2020-12-6]. https://www.hiacode.com/education/new-technology-add-on-payments-ntap-2021/.
[10] CMS. Outlier Payment[EB/OL].2021-12-01[2021-12-06]. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/outlier.
[11] CMS, HHS.Medicare Program; Medicare Program; Change in Methodology for Determining Payment for Extraordinarily High-Cost Cases (Cost Outlier) Under the Acute Care Hospital Inpatient and Long-Term Care Hospital Prospective Payment System[J]. Federal Register, 2003, 68(110): 34494-34515.
[12] CMS HHS. Medicare Program; Explanation of FY2004 Outlier Fixed Loss Threshold as Required by Court Rulings[EB/OL]. 2016-01-22[2016-1-22]. https://www.govinfo.gov/content/pkg/FR-2016-01-22/pdf/2016-01309.pdf.
[13] Busse R, Geissler A, Quentin W, et al.Diagnose-Related Groups in Europe: Moving Towards Transparency, efficiency and quality in hospitals[M]. Germany: Open University Press and WHO Regional Office for Europe, 2011: 131-147.
[14] CMS. Design and development of Diagnosis Related Group (DRG)[EB/OL].2020[2021-12-06]. https://www.cms.gov/icd10m/version37-fullcode-cms/fullcode_cms/Design_and_development_of_the_Diagnosis_Related_Group_(DRGs).pdf.

Accesses

Citation

Detail

段落导航
相关文章

/